Literature DB >> 16373917

Thiazolidinediones: the case for early use.

David M Kendall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16373917     DOI： 10.2337/diacare.29.1.154

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

1.  New oral antidiabetic agents.

Authors:  Paolo Cavallo Perin; Paolo Fornengo
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 2.  Defining and achieving treatment success in patients with type 2 diabetes mellitus.

Authors:  Mark W Stolar
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

Review 3.  Patients With Type 2 Diabetes: Anesthetic Management in the Ambulatory Setting: Part 2: Pharmacology and Guidelines for Perioperative Management.

Authors:  Bryant W Cornelius
Journal:  Anesth Prog       Date:  2017

Review 4.  Apoptosis in pancreatic β-islet cells in Type 2 diabetes.

Authors:  Tatsuo Tomita
Journal:  Bosn J Basic Med Sci       Date:  2016-05-22       Impact factor: 3.363

Review 5.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

6.  A Brief History of the Development of Diabetes Medications.

Authors:  John R White
Journal:  Diabetes Spectr       Date:  2014-05

7.  The management of type 2 diabetic patients with hypoglycaemic agents.

Authors:  Man-Wo Tsang
Journal:  ISRN Endocrinol       Date:  2012-05-07

Review 8.  Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2.

Authors:  Graciliana Lopes; Paula B Andrade; Patrícia Valentão
Journal:  Molecules       Date:  2016-12-30       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.